The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates
Open accessAbstract
The in vitro interaction between terbinafine and the azoles voriconazole, miconazole, and itraconazole against five clinical Scedosporium prolificans isolates after 48 and 72 h of incubation was tested by a microdilution checkerboard (eight-by-twelve) technique. The antifungal effects of the drugs alone and in combination on the fungal biomass as well as on the metabolic activity of fungi were measured using a spectrophotometric method and two colorimetric methods, based on the lowest drug concentrations showed 75 and 50% growth inhibition (MIC-1 and MIC-2, respectively). The nature and the intensity of the interactions were assessed using a nonparametric approach (fractional inhibitory concentration [FIC] index model) and a fully parametric response surface approach (Greco model) of the Loewe additivity (LA) no-interaction theory as well as a nonparametric (Prichard model) and a semiparametric response surface approaches of the Bliss independence (BI) no-interaction theory. Statistically significant synergy was found between each of the three azoles and terbinafine in all cases, although with different intensities. A 27- to 64-fold and 16- to 90-fold reduction of the geometric mean of the azole and terbinafine MICs, respectively, was observed when they were combined, resulting in FIC indices of <1 to 0.02. Using the MIC-1 higher levels of synergy were obtained, , which were more consistent between the two incubation periods than using the MIC-2. The strongest synergy among the azoles was found with miconazole using the BI-based models and with voriconazole using the LA-based models. The synergistic effects both on fungal growth and metabolic activity were more potent after 72 h of incubation. Fully parametric approaches in combination with the modified colorimetric method might prove useful for testing the in vitro interaction of antifungal drugs against filamentous fungi.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
Enzyme and metabolic inhibitors
Webb, J. L. (1963) · Academic Press eBooks · doi:10.5962/bhl.title.7320 · Cited by 1,514
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Berenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
A three-dimensional model to analyze drug-drug interactions
Prichard, M. N., & Shipman, C. (1990) · Antiviral Research · doi:10.1016/0166-3542(90)90001-n · Cited by 544
The expected effect of a combination of agents: the general solution
Berenbaum, M. C. (1985) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(85)80176-4 · Cited by 523
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., et al. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.643-658.2001 · Cited by 444
Terbinafine: Mode of action and properties of the squalene epoxidase inhibition
RYDER, N. S. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb00001.x · Cited by 435
Synergism and Antagonism in Chemotherapy
Chou, T., & Rideout, D. C. (1991) · Cited by 409
Balfour, J. A., & Faulds, D. (1992) · Drugs · doi:10.2165/00003495-199243020-00010 · Cited by 280
Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Donnelly, J. P., & Verweij, P. E. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.8.2949-2954.2000 · Cited by 244
Self-citationAnalysis of Growth Characteristics of Filamentous Fungi in Different Nutrient Media
Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., & Verweij, P. E. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.2.478-484.2001 · Cited by 241
Self-citationIn Vitro Activities of New and Conventional Antifungal Agents against Clinical Scedosporium Isolates
Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Rodriquez-Tudela, J. L., Donnelly, J. P., Verweij, P. E., & the EUROFUNG Network (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.62-68.2002 · Cited by 233
Self-citationGreco, W. R., Park, H. S., & Rustum, Y. M. (1990) · PubMed · Cited by 219
Berenguer, J., Rodríguez-Tudela, J. L., Richard, C., Alvarez, M., Sanz, M. A., Gaztelurrutia, L., Ayats, J., & Martinez-Suarez, J. V. (1997) · Medicine · doi:10.1097/00005792-199707000-00004 · Cited by 213
Cuenca-Estrella, M., Ruiz-Díez, B., Martínez-Suárez, J. V., Monzón, A., & Rodríguez-Tudela, J. L. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.149 · Cited by 212
In Vitro Activities of Four Novel Triazoles against Scedosporium spp
Carrillo, A. J., & Guarro, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2151-2153.2001 · Cited by 182
Clinical Pharmacokinetics of Systemic Antifungal Drugs
Daneshmend, T. K., & Warnock, D. W. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308010-00002 · Cited by 177
Colorimetric Assay for Antifungal Susceptibility Testing of Aspergillus Species
Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Bouman, B. A., Donnelly, J. P., Verweij, P. E., & EUROFUNG Network (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3402-3408.2001 · Cited by 161
Self-citationAntifungal Agents in the 1990s: Current Status and Future Developments
Kauffman, C. A., & Carver, P. L. (1997) · Drugs · doi:10.2165/00003495-199753040-00001 · Cited by 144
Successful Medical Therapy for Deeply Invasive Facial Infection Due to Pythium insidiosum in a Child
Shenep, J. L., English, B. K., Kaufman, L., Pearson, T. A., Thompson, J. W., Kaufman, R. A., Frisch, G., & Rinaldi, M. G. (1998) · Clinical Infectious Diseases · doi:10.1086/515042 · Cited by 142
The Triazole Antifungal Agents: A Review of Itraconazole and Fluconazole
Bailey, E. M., Krakovsky, D. J., & Rybak, M. J. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02561.x · Cited by 141
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species
Ryder, N. S., & Leitner, I. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.91.95 · Cited by 129
The past, present and future of antimycotic combination therapy
Polak, A. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00475.x · Cited by 125
Antifungal Susceptibility Testing: Technical Advances and Potential Clinical Applications
Pfaller, M. A., Rex, J. H., & Rinaldi, M. G. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.5.776 · Cited by 123
The employment of combinations of drugs in the chemotherapy of neoplasia: a review.
GOLDIN, A. S., & Mantel, N. (1957) · PubMed · Cited by 122
The Future of Antifungal Therapy
Graybill, J. R. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s166 · Cited by 119
Meletiadis, J., Mouton, J. W., Rodrı́guez-Tudela, J. L., Meis, J. F. G. M., & Verweij, P. E. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.470-472.2000 · Cited by 109
Self-citationStrategic design and three-dimensional analysis of antiviral drug combinations
Prichard, M. N., Prichard, L. E., & Shipman, C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.540 · Cited by 106
Evaluation of synergism or antagonism for the combined action of antiviral agents
Sühnel, J. (1990) · Antiviral Research · doi:10.1016/0166-3542(90)90042-6 · Cited by 99
Synergism and potentiation with special reference to the combination of structural analogues.
Veldstra, H. (1956) · PubMed · Cited by 96
Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine
Prichard, M. N., Prichard, L. E., Baguley, W. A., Nassiri, M. R., & Shipman, C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1060 · Cited by 92
D’Argenio, D. Z. (1990) · Mathematical Biosciences · doi:10.1016/0025-5564(90)90141-k · Cited by 82
Standardization of antifungal susceptibility testing and clinical relevance.
Espinel-Ingroff, A. V., Barchiesi, F., Hazen, K. C., Martı́nez-Suárez, J. V., & Scalise, G. (1998) · PubMed · Cited by 82
Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Bouman, B. A., Donnelly, P. J., Verweij, P. E., & EUROFUNG Network (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.12.4256-4263.2001 · Cited by 77
Self-citationBarchiesi, F., Francesco, L. F. D., Compagnucci, P., Arzeni, D., Giacometti, A., & Scalise, G. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.1.59 · Cited by 69
Standardization of antifungal susceptibility testing
Cormican, M., & Pfaller, M. A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.4.561 · Cited by 63
Drusano, G. L., D’Argenio, D. Z., Symonds, W., Bilello, P., McDowell, J. A., Sadler, B., Bye, A., & Bilello, J. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2153 · Cited by 47
Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans
Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., & Verweij, P. E. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00089.x · Cited by 44
Self-citationLevasseur, L. M., Greco, W. R., Rustum, Y. M., & Slocum, H. K. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050693 · Cited by 29
Pharmacology and Pharmacokinetics of Traditional Systemic Antifungal Agents
Barriere, S. L. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02598.x · Cited by 25
Cited by
Infections Caused by Scedosporium spp
Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., et al. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00039-07 · Cited by 786
Self-citationMelanized Fungi in Human Disease
Revankar, S. G., & Sutton, D. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-10 · Cited by 569
Tortorano, A. M., Richardson, M., Roilides, E., van Diepeningen, A., Caira, M., Munoz, P., Johnson, E., Meletiadis, J., Pana, Z.-D., Lackner, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12465 · Cited by 523
Self-citationHusain, S., Munoz, P., Forrest, G., Alexander, B. D., Somani, J., Brennan, K., Wagener, M. M., & Singh, N. (2005) · Clinical Infectious Diseases · doi:10.1086/426445 · Cited by 401
Combination Treatment of Invasive Fungal Infections
Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., & Ghannoum, M. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.163-194.2005 · Cited by 308
Metadata
- Authors
- Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., & Verweij, P. E.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2003-01
- Volume
- 47
- Issue
- 1
- Pages
- 106-117
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2170477120
- Cited by
- 253
- References
- 44
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.